Neosaxitoxin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNeosaxitoxin
Drug Alias Name新石房蛤毒素新岩蛤毒素NeoSTX
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionSodium channel protein type IV alpha subunit blockers
TargetsSodium channel protein type IV alpha subunit
Therapy Area/IndicationsAnesthesia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsChile
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGrunenthal GmbhProteusBoston Children'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrünenthal GmbHUniversity Of Chile
Active IndicationsN/A
Inactive IndicationsAnesthesia

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG